StockNews.com assumed coverage on shares of OncoCyte (NASDAQ:OCX – Free Report) in a report published on Saturday. The brokerage issued a sell rating on the stock. Separately, Needham & Company LLC lowered their price objective on OncoCyte from $9.00 to $4.25 and set a buy rating for the company in a research report on Thursday, […]
Equities research analysts at StockNews.com started coverage on shares of OncoCyte (NASDAQ:OCX – Get Free Report) in a research note issued on Friday. The brokerage set a “sell” rating on the stock. Separately, Needham & Company LLC lowered their price objective on shares of OncoCyte from $9.00 to $4.25 and set a “buy” rating for […]
Investment analysts at StockNews.com started coverage on shares of OncoCyte (NASDAQ:OCX – Get Free Report) in a research note issued on Monday. The firm set a “sell” rating on the stock. OncoCyte Trading Down 1.7 % NASDAQ OCX traded down $0.06 during mid-day trading on Monday, hitting $3.52. The company’s stock had a trading volume […]
StockNews.com began coverage on shares of OncoCyte (NASDAQ:OCX – Free Report) in a research report released on Thursday morning. The firm issued a sell rating on the stock. OncoCyte Trading Down 1.7 % Shares of NASDAQ:OCX traded down $0.07 during trading on Thursday, reaching $3.96. 16,981 shares of the stock were exchanged, compared to its […]
Equities researchers at StockNews.com assumed coverage on shares of OncoCyte (NYSE:OCX – Get Free Report) in a research note issued on Saturday. The firm set a “sell” rating on the stock. OncoCyte Stock Performance OncoCyte Company Profile (Get Free Report) OncoCyte Corporation, a molecular diagnostics company, research, develops, and commercializes proprietary laboratory-developed tests for the […]